Clinical Trial Update: A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects [Phase 1]

View source ↗

Summary

Phase 1 study completed a single-dose safety and pharmacokinetic evaluation of GSK2256294 in healthy young and elderly male subjects, with chronic obstructive p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK2256294 (GSK2256294)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED